Liraglutide 14403-3400-03
- Manufacturer
- Hybio Pharmaceutical Co., Ltd. (pingshan Factory)
- Dosage Form
- Injection, Solution
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- December 24, 2024
- Listing Expires
- December 31, 2026
- Application
- ANDA215503
Need to source Liraglutide? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Liraglutide | 18 mg/3mL |
Drug Class
GLP-1 Receptor Agonist [EPC]GLP-1 Receptor Agonist [EPC]Glucagon-Like Peptide 1 [CS]
Selected Package
14403-3400-03Selected3 SYRINGE, PLASTIC in 1 CARTON (14403-3400-3) / 3 mL in 1 SYRINGE, PLASTIC (14403-3400-1)